Page 2 - Nyse Crl News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse crl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Crl Today - Breaking & Trending Today
CNB Bank boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,962 shares of the medical research company’s stock after purchasing an additional 263 shares during the period. CNB Bank’s holdings in Charles […] ....
Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The […] ....
Sequoia Financial Advisors LLC boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1,256.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,108 shares of the medical research company’s stock after purchasing an additional 13,068 shares […] ....
Impax Asset Management Group plc decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 64.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,115 shares of the medical research company’s stock after […] ....
Harbor Investment Advisory LLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 944 shares of the medical research company’s stock after purchasing an additional […] ....